日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Reclassification of RAS/BRAF allele mutations predicts the survival benefit of triplet chemotherapy in metastatic colorectal cancer

RAS/BRAF等位基因突变的重新分类可预测转移性结直肠癌患者接受三联化疗的生存获益

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359231225035
Zhang, Xiang; Ma, Haizhong; He, Yinjun; He, Wenguang; Chen, Nan; Li, Yandong; Zhong, Weixiang; Wu, Guosheng; Zhou, Xile; Hua, Hanju; Ye, Feng; Cai, Hui; Jiang, Weiqin
肿瘤
肠癌
肿瘤免疫
BRAF
RAS
发表日期：2024
文献求助 收藏

Soluble PD-L1: a potential dynamic predictive biomarker for immunotherapy in patients with proficient mismatch repair colorectal cancer

可溶性PD-L1：一种潜在的动态预测性生物标志物，可用于预测错配修复功能正常的结直肠癌患者的免疫治疗

期刊:Journal of Translational Medicine
影响因子:6.1
doi:10.1186/s12967-023-03879-0
Yinjun He # ，Xiang Zhang # ，Ming Zhu # ，Wenguang He ，Hanju Hua ，Feng Ye ，Xile Zhou ，Nan Chen ，Yandong Li ，Weixiang Zhong ，Guosheng Wu ，Hui Cai # ，Weiqin Jiang #
PD-L1
肿瘤
免疫/内分泌
肠癌
肿瘤免疫
发表日期：2023
文献求助 收藏

Metastatic sites and lesion numbers cooperated to predict efficacy of PD-1 inhibitor-based combination therapy for patients with metastatic colorectal cancer

转移部位和病灶数量共同预测了基于PD-1抑制剂的联合疗法对转移性结直肠癌患者的疗效。

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.5959
Jiang, Weiqin; He, Yinjun; He, Wenguang; Zhang, Xiang; Chen, Nan; Li, Yandong; Zhong, Weixiang; Wu, Guosheng; Zhou, Xile; Hua, Hanju; Ye, Feng
肿瘤
肠癌
肿瘤免疫
PD-1
发表日期：2023
文献求助 收藏